For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...

CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...

The gene editing market is experiencing significant growth, with a projected annual growth rate (CAGR) of 16-18% in the coming years. This expansion is fueled by breakthroughs in gene-editing ...

If approved, Regeneron and Tessera's TSRA-196 could become the first curative therapy to reach patients with AATD, who have ...

CRISPR technology, a revolutionary tool in genetic engineering, has empowered Lambert's iGEM team to tackle a significant health issue: Lyme disease, which affects nearly half a million Americans ...

The Lambert High School team, consisting of young genetic engineers led by Sean Lee and Avani Karthik, aimed to address a significant issue: the difficulty in diagnosing Lyme disease during its early ...

Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...

Following the weekend data presentation, Citizens voiced optimism regarding CRISPR’s in-vivo projects. The firm noted some ...

The rapid spread of animal diseases and pathogen evolution have long posed significant threats to the healthy development of animal husbandry.

To compile our list of the best short squeeze stocks, we made use of stocks screeners to note down stocks with significant ...

Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics ...